Recent data from the Hong Kong Stock Exchange reveals that on July 10th, JPMorgan Chase & Co. increased its holding in Pharmaron (HKEX: 03759) by approximately 1.29114 million shares.

The transaction was executed at an average price of about HK$22.1068 per share, resulting in a total investment of roughly HK$28.543 million.

Following this acquisition, JPMorgan's total shareholding in the company now stands at approximately 26.3828 million shares, representing a stake of about 7.32%.